Collisions YYC

In this episode, you’ll learn from Mads Daugaard, President and Chief Scientific Officer of Rakovina Therapeutics, who has dedicated his life to developing innovative treatments for cancer. Mads shares his insights as a successful 3X biotech entrepreneur, sharing what it takes to succeed in this cutting-edge industry. He also discusses his ground-breaking research into DNA-targeted cancer treatments, where Canada ranks globally in biotech, and what investors need to keep in mind when considering investing in this vertical.

Show Notes

Investing in biotech can be a risky proposition - often requiring significant sunk costs in research and development with no guarantee of success. Many scientists also struggle to commercialize their discoveries, failing to adequately protect them through intellectual property and patents. However, those who are able to navigate these challenges and successfully move their inventions from research publications to the marketplace can reap tremendous rewards. Discover the opportunities available in Alberta and Canada for becoming a world leader in biotech investment.

What is Collisions YYC?

Tired of the same old news cycle? Get informed on what’s happening in businesses in Calgary, Alberta and beyond with Collisions YYC.

Tyler Chisholm hosts Alberta’s best and brightest minds who are shaping the very landscape of our province with their work in fields like Technology, FinTech, Energy, Healthcare, Education, AI, and more. Tyler’s inherent curiosity and exploratory style fuel candid conversations with the people who are driving change in our city, our province and the world.

Connect with us on social media:
https://www.instagram.com/collisionsyyc